Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-16 · accession 0001562180-21-007809 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-20 | 2021-12-16+ | SNDX | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.94 | -85.4K | 17.7K | -83% | -$1.70M |
| DM | 2021-12-20 | 2021-12-16+ | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.64 | +85.4K | 19.3K | New | +$652.3K |
| DM | 2021-12-20 | 2021-12-16+ | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $0.00 | -85.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-16 | S | D | 22,715 | $19.08 | 17,659 | D | — | — | (F2) The sale prices ranged from $19.00 to $19.30. |
| 2 | Common | Common Stock | 2021-12-16 | M | A | 22,715 | $6.38 | 40,374 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-20 | M | A | 45,000 | $8.77 | 62,659 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-20 | M | A | 16,000 | $6.38 | 33,659 | D | — | — | |
| 5 | Common | Common Stock | 2021-12-20 | S | D | 16,000 | $20.29 | 17,659 | D | — | — | (F4) The sale prices ranged from $19.17 to $21.01 |
| 6 | Common | Common Stock | 2021-12-17 | M | A | 1,676 | $6.38 | 19,335 | D | — | — | |
| 7 | Common | Common Stock | 2021-12-17 | S | D | 1,676 | $19.02 | 17,659 | D | — | — | (F3) The sale prices ranged from $19.00 to $19.06. |
| 8 | Common | Common Stock | 2021-12-20 | S | D | 45,000 | $20.29 | 17,659 | D | — | — | (F4) The sale prices ranged from $19.17 to $21.01 |
| 9 | Derivative | Stock Options (Right to buy) | 2021-12-20 | M | D | 16,000 | $0.00 | 0 | D | $6.38 · — to 2029-02-06 | 16,000 Common Stock | (F5) This option is fully vested. |
| 10 | Derivative | Stock Options (Right to buy) | 2021-12-20 | M | D | 45,000 | $0.00 | 0 | D | $8.77 · — to 2027-02-06 | 45,000 Common Stock | (F5) This option is fully vested. |
| 11 | Derivative | Stock Options (Right to buy) | 2021-12-17 | M | D | 1,676 | $0.00 | 0 | D | $6.38 · — to 2029-02-06 | 1,676 Common Stock | (F5) This option is fully vested. |
| 12 | Derivative | Stock Options (Right to buy) | 2021-12-16 | M | D | 22,715 | $0.00 | 0 | D | $6.38 · — to 2029-02-06 | 22,715 Common Stock | (F5) This option is fully vested. |